To further ascertain whether miRNAs involved in the mechanism for LY6K and ERα are correlated with clinical outcomes in breast cancer patients, we first investigated the inverse correlation between LY6K and ERα expression in breast primary tumor samples obtained from oncomineTM. Here, ESR1 is linked to breast cancer.